ArticleNature communications2021
Author Correction: An investigation of causal relationships between prediabetes and vascular complications.
Pascal M Mutie, Hugo Pomares-Millan, Naeimeh Atabaki-Pasdar, Nina Jordan, Rachel Adams, Nicole L Daly, Juan Fernandes Tajes, Giuseppe N Giordano, Paul W Franks
Abstract readPublished Erratum
In one paragraphArticle in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
9 authors.
Pascal M MutieGenetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Clinical Research Centre, Lund University, Skåne University Hospital, Jan Waldenströms gata 35, Malmö, SE-20502, Sweden.
Hugo Pomares-MillanGenetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Clinical Research Centre, Lund University, Skåne University Hospital, Jan Waldenströms gata 35, Malmö, SE-20502, Sweden.ORCID http://orcid.org/0000-0001-9245-4576 Naeimeh Atabaki-PasdarGenetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Clinical Research Centre, Lund University, Skåne University Hospital, Jan Waldenströms gata 35, Malmö, SE-20502, Sweden.
Nina JordanRegulatory Affairs Intelligence, Novo Nordisk A/S, Copenhagen, Denmark.
Nicole L DalyRegulatory Affairs-Neuroscience and Cardiovascular Metabolism, Janssen, High Wycombe, UK.
Juan Fernandes TajesGenetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Clinical Research Centre, Lund University, Skåne University Hospital, Jan Waldenströms gata 35, Malmö, SE-20502, Sweden.
Giuseppe N GiordanoGenetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Clinical Research Centre, Lund University, Skåne University Hospital, Jan Waldenströms gata 35, Malmö, SE-20502, Sweden.ORCID http://orcid.org/0000-0002-6719-6680 Paul W FranksGenetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Clinical Research Centre, Lund University, Skåne University Hospital, Jan Waldenströms gata 35, Malmö, SE-20502, Sweden. paul.franks@med.lu.se.ORCID http://orcid.org/0000-0002-0520-7604 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID33398036
PMCPMC7782799
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390